Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple foot tests could prevent thousands of diabetes amputations

NCT ID NCT05009602

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested several simple bedside tests—like ankle and toe blood pressure measurements and handheld Dopplers—to see how well they detect poor leg circulation (peripheral arterial disease) in 604 people with diabetes. The results were compared to advanced imaging scans (CTA or MRA). The goal is to find the most accurate and cost-effective way to diagnose circulation problems early and prevent leg amputations.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could identify the most accurate and cost-effective bedside test for detecting poor leg circulation in people with diabetes, potentially reducing amputations.
What could go wrong
This is a completed diagnostic accuracy study, not a treatment trial. The results may not change clinical practice if no test proves clearly superior or cost-effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

604 people

The number who actually took part.

Started

Mar 2022

Finished

Feb 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients with a diagnosis of diabetes.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged ≥18 years * Known history of diabetes Exclusion Criteria: * PAD status known on imaging * Known history of PAD intervention * CTA and MRA contraindications- renal impairment, pregnancy, contrast medium hypersensitivity/allergy, non-compatible implants (MRA only). * Unable to provide appropriate informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Critical limb ischemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cardiff and Vale UHB

    Cardiff, CF14 4XW, United Kingdom

  • Central London Community Healthcare NHS Trust sites

    London, NW1 5JD, United Kingdom

  • Chelsea and Westminster Hospital NHS Foundation Trust

    London, SW10 9NH, United Kingdom

  • Hammersmith and Fulham Partnership

    London, United Kingdom

  • Hull University Teaching Hospitals NHS Trust

    Hull, HU3 2JZ, United Kingdom

  • Imperial College Healthcare NHS Trust

    London, W6 8RF, United Kingdom

  • Mid and South Essex NHS Foundation Trust

    Basildon, SS16 5NL, United Kingdom

  • NHS Greater Glasgow and Clyde

    Glasgow, G12 0XH, United Kingdom

  • Nottingham University Hospitals (NUH) NHS Trust

    Nottingham, NG5 1PB, United Kingdom

  • Oxford University Hospitals NHS Foundation Trust

    Oxford, OX4 2PG, United Kingdom

  • South Tees Hospitals NHS Foundation Trust

    Middlesbrough, TS4 3BW, United Kingdom

  • St George's University Hospitals NHS Foundation Trust

    London, SW17 0QT, United Kingdom

  • University Hospitals Plymouth NHS Trust

    Plymouth, PL6 8DH, United Kingdom

  • University Hospitals Southampton NHS Foundation Trust

    Southampton, SO16 6YD, United Kingdom

  • University Hospitals of Derby and Burton NHS Foundation Trust

    Derby, DE22 3NE, United Kingdom

  • University Hospitals of Leicester NHS Trust

    Leicester, LE1 5WW, United Kingdom

  • Worcestershire Acute Hospitals NHS Trust

    Worcester, WR5 1DD, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.